Relationship of Serotonergic Antidepressants and Need for Blood Transfusion in Orthopedic Surgical Patients

Archives of Internal Medicine

Volumn 163, Issue 19, 2003, Pages 2354-2358

  Movig, Kris L L ^a,c   Janssen, Michiel W H E ^b   De Waal Malefijt, Jan ^b   Kabel, Peter J ^b   Eeufkens, Hubert G M ^c   Egberts, Antoine C G ^a,b,c  

^a GGZ Midden Brabant   (Netherlands)

^b CPRLab   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDEPRESSANT AGENT; ANTIVITAMIN K; CALCIUM CHANNEL BLOCKING AGENT; CLOMIPRAMINE; CORTICOSTEROID; FLUOXETINE; FLUVOXAMINE; IRON; METHOTREXATE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; SURGICAL RISK; THROMBOCYTE ACTIVATION;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; HUMANS; MALE; ORTHOPEDIC PROCEDURES; PLATELET ACTIVATION; SEROTONIN UPTAKE INHIBITORS;

EID: 0142181146     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.19.2354     Document Type: Article

References (39)

1. Egberts AC, Leufkens HG, Hofman A, Hoes AW. Incidence of antidepressant drug use in older adults and association with chronic diseases: the Rotterdam Study. Int Clin Psychopharmacol. 1997;12:217-223.
2. Mourilhe P, Stokes PE. Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression. Drug Saf. 1998;18:57-82.
3. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet. 1998;351:1303-1307.
4. Thapa PB, Gideon P, Cost TW, Milam AB, Ray WA. Antidepressants and the risk of falls among nursing home residents. N Engl J Med. 1998;339:875-882.
5. Pacher P, Ungvari Z. Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channels. Med Hypotheses. 2001;57:469-471.
6. Dodd RY. Current viral risks of blood and blood products. Ann Med. 2000;32:469-474.
7. Vandel P, Vandel S, Kantelip JP. SSRI-induced bleeding: two case reports. Therapie. 2001;56:445-447.
8. Lake MB, Birmaher B, Wassick S, Mathos K, Yelovich AK. Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence. J Child Adolesc Psychopharmacol. 2000;10:35-38.
9. Cooper TA, Valcour VG, Gibbons RB, O'Brien-Falls K. Spontaneous ecchymoses due to paroxetine administration. Am J Med. 1998;104:197-198.
10. Tielens JA. Vitamin C for paroxetine- and fluvoxamine-associated bleeding. Am J Psychiatry. 1997;154:883-884.
11. Leung M, Shore R. Fluvoxamine-associated bleeding. Can J Psychiatry. 1996;41:604-605.
12. Wilmshurst PT, Kumar AV. Subhyaloid haemorrhage with fluoxetine [letter]. Eye. 1996;10:141.
13. Calhoun JW, Calhoun DD. Prolonged bleeding time in a patient treated with sertraline [letter]. Am J Psychiatry. 1996;153:443.
14. Pai VB, Kelly MW. Bruising associated with the use of fluoxetine. Ann Pharmacother. 1996;30:786-788.
15. Ottervanger JP, Stricker BH, Huls J, Weeda JN. Bleeding attributed to the intake of paroxetine. Am J Psychiatry. 1994;151:781-782.
16. Ottervanger JP, van den Bemt PM, de Koning GH, Stricker BH. Risk of hemorrhage with the use of fluoxetine (Prozac) or fluvoxamine (Fevarin). Ned Tijdschr Geneeskd. 1993;137:259-261.
17. Gunzberger DW, Martinez D. Adverse vascular effects associated with fluoxetine [letter]. Am J Psychiatry. 1992;149:1751.
18. Aranth J, Lindberg C. Bleeding, a side effect of fluoxetine [letter]. Am J Psychiatry. 1992;149:412.
19. Yaryura-Tobias JA, Kirschen H, Ninan P, Mosberg HJ. Fluoxetine and bleeding in obsessive-compulsive disorder [letter]. Am J Psychiatry. 1991;148:949.
20. Evans TG, Buys SS, Rodgers GM. Acquired abnormalities of platelet function [letter]. N Engl J Med. 1991;324:1671.
21. Humphries JE, Wheby MS, VandenBerg SR. Fluoxetine and the bleeding time. Arch Pathol Lab Med. 1990;114:727-728.
22. van Walraven C, Mamdani MM, Wells PS, Williams JI. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ. 2001;323:655-658.
23. Layton D, Clark DW, Pearce GL, Shakir SA. Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol. 2001;57:167-176.
24. de Abajo FJ, Jick H, Derby L, Jick S, Schmitz S. Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. BrJ Clin Pharmacol. 2000;50:43-47.
25. de Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal-bleeding: population based case-control study. BMJ. 1999;319:1106-1109.
26. Alderman CP, Seshadri P, Ben-Tovim DI. Effects of serotonin reuptake inhibitors on hemostasis. Ann Pharmacother. 1996;30:1232-1234.
27. Lau HS, de Boer A, Beuning KS, Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol. 1997;50:619-625.
28. Tatsumi M, Groshan K, Blakely RD, Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997;340:249-258.
29. Li N, Wallen NH, Ladievardi M, Hjemdahl P. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis. 1997;8:517-523.
30. Naesh O, Hindberg I, Bruun AB. Decreased reuptake of serotonin in human platelets after surgery. Clin Physiol. 2001;21:39-43.
31. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation. 2001;104:1894-1898.
32. Robinson CM, Christie J, Malcolm-Smith N. Nonsteroidal antiinflammatory drugs, perioperative blood loss, and transfusion requirements in elective hip arthroplasty. J Arthroplasty. 1993;8:607-610.
33. Connelly CS, Panush RS. Should nonsteroidal anti-inflammatory drugs be stopped before elective surgery? Arch Intern Med. 1991;151:1963-1966.
34. Fauno P, Petersen KD, Husted SE. Increased blood loss after preoperative NSAID: retrospective study of 186 hip arthroplasties. Acta Orthop Scand. 1993;64:522-524.
35. Zuccala G, Pahor M, Landi F, et al. Use of calcium antagonists and need for perioperative transfusion in older patients with hip fracture: observational study. BMJ. 1997;314:643-644.
36. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999;81:2-10.
37. Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem. 1994;40:288-295.
38. Bakish D, Cavazzoni P, Chudzik J, Ravindran A, Hrdina PD. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biol Psychiatry. 1997;41:184-190.
39. Tamir L, Fradin Z, Fridlander M, et al. Recombinant human erythropoietin reduces allogeneic blood transfusion requirements in patients undergoing major orthopedic surgery. Haematologia. 2000;30:193-201.